Early versus late surgery in patients with intestinal behçet disease

Diseases of the Colon and Rectum

Volumn 55, Issue 1, 2012, Pages 65-71

  Jung, Yoon Suk ^a   Hong, Sung Pil ^a   Kim, Tae Il ^a   Kim, Won Ho ^a   Cheon, Jae Hee ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Early surgery; Intestinal Beh et disease; Late surgery; Recurrence; Reoperation

Indexed keywords

ADULT; BEHCET DISEASE; CHRONIC DISEASE; EARLY SURGERY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTESTINAL BEHCET DISEASE; INTESTINE SURGERY; LATE SURGERY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PROGNOSIS; RECURRENT DISEASE; REOPERATION; REVIEW;

ADULT; BEHCET SYNDROME; COHORT STUDIES; FEMALE; HUMANS; INTESTINAL DISEASES; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84863028154     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e318238b57e     Document Type: Review

References (44)

1. Kobayashi K, Ueno F, Bito S, et al. Development of consensus statements for the diagnosis and management of intestinal Behc ̧et's disease using a modified Delphi approach. J Gastroenterol. 2007;42:737-745. (Pubitemid 47456761)
2. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease.NEngl J Med. 1999;341:1284-1291.
3. Cheon JH, Kim ES, Shin SJ, et al. Development and validation of novel diagnostic criteria for intestinal Behçet's disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol. 2009;104: 2492-2499.
4. Shimizu T, Ehrlich GE, Inaba G, Hayashi K. Behçet disease (Behc ̧et syndrome). Semin Arthritis Rheum. 1979;8:223-260.
5. Bang D, Yoon KH, Chung HG, Choi EH, Lee ES, Lee S. Epidemiological and clinical features of Behçet's disease in Korea. Yonsei Med J. 1997;38:428-436. (Pubitemid 128516404)
6. Chang HK, Kim JW. The clinical features of Behçet's disease in Yongdong districts: analysis of a cohort followed from 1997 to 2001. J Korean Med Sci. 2002;17:784-789.
7. Iida M, Kobayashi H, Matsumoto T, et al. Postoperative recurrence in patients with intestinal Behçet's disease. Dis Colon Rectum. 1994;37:16-21. (Pubitemid 24064264)
8. Iida M, Kobayashi H, Matsumoto T, et al. Intestinal Behçet disease: serial changes at radiography. Radiology. 1993;188:65-69. (Pubitemid 23183100)
9. Kasahara Y, Tanaka S, Nishino M, Umemura H, Shiraha S, Kuyama T. Intestinal involvement in Behçet's disease: review of 136 surgical cases in the Japanese literature. Dis Colon Rectum. 1981; 24:103-106. (Pubitemid 11113357)
10. Baba S, Maruta M, Ando K, Teramoto T, Endo I. Intestinal Behc ̧et's disease: report of five cases. Dis Colon Rectum. 1976;19: 428-440.
11. Goldstein SJ, Crooks DJ. Colitis in Behçet's syndrome: two new cases. Radiology. 1978;128:321-323. (Pubitemid 8372256)
12. Masugi J, Matsui T, Fujimori T, Maeda S. A case of Behçet's disease with multiple longitudinal ulcers all over the colon. Am J Gastroenterol. 1994;89:778-780. (Pubitemid 24132065)
13. Smith JA, Siddiqui D. Intestinal Behçet's disease presenting as a massive acute lower gastrointestinal bleed. Dig Dis Sci. 2002;47: 517-521. (Pubitemid 34218877)
14. Choi IJ, Kim JS, Cha SD, et al. Long-term clinical course and prognostic factors in intestinal Behçet's disease. Dis Colon Rectum. 2000;43:692-700. (Pubitemid 30324610)
15. Jung YS, Yoon JY, Lee JH, et al. Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behçet's disease. Inflamm Bowel Dis. 2011;17:1594-1602.
16. Cheon JH, Han DS, Park JY, et al. Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet's disease. Inflamm Bowel Dis. 2011;17:605-613.
17. Kim JS, Lim SH, Choi IJ, et al. Prediction of the clinical course of Behçet's colitis according to macroscopic classification by colonoscopy. Endoscopy. 2000;32:635-640. (Pubitemid 30458632)
18. Chung MJ, Cheon JH, Kim SU, et al. Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease. J Clin Gastroenterol. 2010; 44:e116-e122.
19. Moon CM, Cheon JH, Shin JK, et al. Prediction of free bowel perforation in patients with intestinal Behçet's disease using clinical and colonoscopic findings. Dig Dis Sci. 2010;55:2904-2911.
20. Latella G, Cocco A, Angelucci E, et al. Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen. Dig Liver Dis. 2009;41:269-276.
21. Aratari A, Papi C, Leandro G, Viscido A, Capurso L, Caprilli R. Early versus late surgery for ileo-caecal Crohn's disease. Aliment Pharmacol Ther. 2007;26:1303-1312. (Pubitemid 350045607)
22. Hulten L. Surgical management and strategy in classical Crohn's disease. Int Surg. 1992;77:2-8.
23. Fasth S, Hellberg R, Hulten L, Magnusson O. Early complications after surgical treatment for Crohn's disease with particular reference to factors affecting their development. Acta Chir Scand. 1980;146:519-526. (Pubitemid 11167079)
24. Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology. 1994;106:287-296. (Pubitemid 24041204)
25. Cohen RD. The quality of life in patients with Crohn's disease. Aliment Pharmacol Ther. 2002;16:1603-1609.
26. Thirlby RC, Land JC, Fenster LF, Lonborg R. Effect of surgery on health-related quality of life in patients with inflammatory bowel disease: a prospective study. Arch Surg. 1998;133:826-832. (Pubitemid 28374275)
27. Thirlby RC, Sobrino MA, Randall JB. The long-term benefit of surgery on health-related quality of life in patients with inflammatory bowel disease. Arch Surg. 2001;136:521-527. (Pubitemid 32417541)
28. Siassi M, Weiger A, Hohenberger W, Kessler H. Changes in surgical therapy for Crohn's disease over 33 years: a prospective longitudinal study. Int J Colorectal Dis. 2007;22:319-324. (Pubitemid 46071110)
29. Windsor AC. Ileal Crohn's disease is best treated by surgery. Gut. 2002;51:11-12. (Pubitemid 34717735)
30. Weston LA, Roberts PL, Schoetz DJ Jr, Coller JA, Murray JJ, Rusin LC. Ileocolic resection for acute presentation of Crohn's disease of the ileum. Dis Colon Rectum. 1996;39:841-846. (Pubitemid 26332458)
31. Lee KS, Kim SJ, Lee BC, Yoon DS, Lee WJ, Chi HS. Surgical treatment of intestinal Behçet's disease. Yonsei Med J. 1997;38: 455-460. (Pubitemid 128516407)
32. Naganuma M, Iwao Y, Inoue N, et al. Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Behçet's disease. Am J Gastroenterol. 2000;95: 2848-2851.
33. Bozkurt M, Torin G, Aksakal B, Ataoglu O. Behçet's disease and surgical intervention. Int J Dermatol. 1992;31:571-573.
34. Yoo HM, Han KH, Kim PS, et al. Clinical features of intestinal Behçet's disease and therapeutic effects of sulfasalazine. Korean J Gastroenterol. 1997;29:465-472.
35. Houman MH, Hamzaoui K. Promising new therapies for Behc ̧et's disease. Eur J Intern Med. 2006;17:163-169.
36. Sonta T, Araki Y, Koubokawa M, et al. The beneficial effect of mesalazine on esophageal ulcers in intestinal Behçet's disease. J Clin Gastroenterol. 2000;30:195-199.
37. Matsukawa M, Yamasaki T, Kouda T, Kurihara M. Endoscopic therapy with absolute ethanol for postoperative recurrent ulcers in intestinal Behçet's disease, and simple ulcers. J Gastroenterol. 2001;36:255-258. (Pubitemid 32427791)
38. Caprilli R, Gassull MA, Escher JC, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut. 2006 ;55(suppl 1):i36-i58. (Pubitemid 43268292)
39. Travis SP, Stange EF, Lemann M, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut. 2006 ;55(suppl 1):i16-i35. (Pubitemid 43268291)
40. Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut. 2005; 54:237-241. (Pubitemid 40139240)
41. Chang JT, Lichtenstein GR. Drug insight: antagonists of tumornecrosis factor-alpha in the treatment of inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol. 2006;3:220-228.
42. Siegel CA, Hur C, Korzenik JR, Gazelle GS, Sands BE. Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol. 2006;4:1017-1024; quiz 1976. (Pubitemid 44137437)
43. Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001;121:255-260. (Pubitemid 32729372)
44. Vader JP, Froehlich F, Juillerat P, et al. Appropriate treatment for Crohn's disease: methodology and summary results of a multidisciplinary international expert panel approach-EPACT. Digestion. 2006;73:237-248. (Pubitemid 44448885)